Related Experiment Video
Updated: Sep 23, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Recent advances in temporal arteritis
Carol Redillas1, Seymour Solomon
1Department of Neurology, Marshfield Clinic, 1000 N. Oak Avenue, Marshfield, WI 54449, USA. carolR@pol.net
Abstract:
Temporal arteritis was first described in the late nineteenth century. Despite considerable progress in understanding the disease, its rarity in the young and in those who are not of Scandinavian ethnicity remains unexplained. Microbiologic agents and immunologic mechanisms have been implicated as causative factors. Although steroids remain the drug of choice, the use of other immunologic therapies has been proposed. This paper reviews the disease's history, probable etiologies, clinical manifestations, and its diagnostic and treatment challenges.